-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Breakdown: TScan Therapeutics Q4

Benzinga·03/04/2026 12:12:09
Listen to the news

TScan Therapeutics (NASDAQ:TCRX) announced its Q4 earnings on Wednesday, March 4, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

TScan Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.18 versus an estimate of $-0.27.

Revenue was up $1.90 million from the same period last year.

Analysis of Past Earnings

The company beat on EPS by $0.06 in the previous quarter, leading to a 5.04% drop share price change the next day.

Here's a look at TScan Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.34 -0.31 -0.28 -0.28
EPS Actual -0.28 -0.28 -0.26 -0.29
Revenue Estimate 2.47M 1.56M 1.08M 1.51M
Revenue Actual 2.51M 3.08M 2.17M 665K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for TScan Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.